Life sciences companies are responding to a global health care system in transition as treatment shifts from traditional clinics to home- and retail-based care. Facilitating the shift, medical technology (medtech) increasingly connects patients with providers for care based on real-time biometrics, and both medtech and pharmaceutical companies are working to strengthen patient interactions through education and enhanced support.